Soluble suppression of tumorigenicity 2 associated with microvascular obstruction in patients with ST-segment

Xinjia Du1, Jiahua Liu1, Jingfang Zhou1

  • 1Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.

PubMed
Abstract

Insights

Soluble suppression of tumorigenicity 2 (sST2) is linked to microvascular obstruction (MVO) in ST-elevation myocardial infarction (STEMI) patients post-percutaneous coronary intervention. Including sST2 improves risk prediction for MVO.

Area of Science:

  • Cardiology
  • Biomarkers
  • Myocardial Infarction Research

Background:

  • Microvascular obstruction (MVO) affects 50% of ST-elevation myocardial infarction (STEMI) patients after percutaneous coronary intervention (PCI).
  • MVO correlates with inflammation, fibrosis, and poor clinical outcomes.
  • Soluble suppression of tumorigenicity 2 (sST2) indicates inflammation and fibrosis, but its role in STEMI-related MVO is unclear.

Purpose of the Study:

  • To investigate the association between sST2 levels and MVO in STEMI patients undergoing primary PCI (pPCI).
  • To determine if sST2 can enhance risk stratification for MVO.

Main Methods:

  • Retrospective analysis of 315 STEMI patients who underwent pPCI.
  • Cardiac magnetic resonance imaging (CMR) assessed MVO and myocardial infarction characteristics.
  • Serum sST2 levels were measured upon admission.

Main Results:

  • Multivariate analysis identified sST2 as an independent predictor of MVO (OR 1.01, p<0.001).
  • Other independent predictors included peak high-sensitivity troponin T, peak C-reactive protein, left ventricular ejection fraction, and age.
  • sST2 levels were significantly associated with the presence of MVO.

Conclusions:

  • sST2 is significantly associated with MVO in STEMI patients post-pPCI.
  • Integrating sST2 into risk models improves the prediction of MVO.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K